Nature Outlook 

Spinoff Prize 2023

Academic research constantly creates and disperses seeds of scientific insight. Occasionally, these seeds land on the fertile soil of commercial interest, and a new business takes root. The innovation pathway from university laboratory to start-up company is an essential part of the dynamic. This Outlook profiles the five companies selected as Finalists for The Spinoff Prize 2023, as well as the seven that made the long-list. All 12 were recognized by the panel of judges as having extraordinary potential to develop products and technologies that will change the way we live and work.

Illustration showing suitcase with the contents under a microscope

This Nature Outlook is editorially independent, produced with financial support from a third party. About this content.

Nature is pleased to acknowledge financial support from Merck in producing this Outlook. The sponsor retains sole responsibility for the following message.

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

On the occasion of its 350th anniversary, Merck initiated the Curious – Future Insight™ conference, where some of the world’s brightest scientists and most accomplished entrepreneurs come together to explore the future of science & technology; solving the challenges of today and enabling the dreams of a better tomorrow.

The Curious2024 – Future Insight™ conference, now organized by the non-profit Future Insight Association, will take place July 10-11, 2024. To register, please visit curiousfutureinsight.org.

Read sponsor feature